𝔖 Bobbio Scriptorium

✦ LIBER ✦

Caspofungin as First-Line Therapy for the Treatment of Invasive Aspergillosis After Thoracic Organ Transplantation

✍ Scribed by Jan Groetzner; Ingo Kaczmarek; Thorsten Wittwer; Justus Strauch; Bruno Meiser; Thorsten Wahlers; Sabine Daebritz; Bruno Reichart

Book ID: 116520292
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 191 KB
Volume: 27
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2007.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Caspofungin (CSF) for invasive aspergill

Caspofungin (CSF) for invasive aspergillosis after thoracic organ transplantation: first experience in 10 patients

✍ J Groetzner; P Landwehr; I Kaczmarek; M Mueller; I Adamidis; M Weis; P Ueberfuhr 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Bortezomib, thalidomide, dexamethasone i

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

✍ Hyeon-Seok Eom; Yeo-Kyeoung Kim; Joo-Seop Chung; Kihyun Kim; Hyo Jung Kim; Ho Yo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 153 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB